Mariner
CLSD

Mariner’s Clearside Biomedical CLSD Stock Holding History

Mariner’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,263
Closed -$15.2K – 3597
2025
Q2 		$15.2K Hold
1,263
– – ﹤0.01% 3440
2025
Q1 		$17.4K Hold
1,263
– – ﹤0.01% 3385
2024
Q4 		$18K Hold
1,263
– – ﹤0.01% 3351
2024
Q3 		$24.1K Hold
1,263
– – ﹤0.01% 3238
2024
Q2 		$24.6K Hold
1,263
– – ﹤0.01% 3098
2024
Q1 		$29K Hold
1,263
– – ﹤0.01% 3071
2023
Q4 		$22.2K Buy
+1,263
New +$18K ﹤0.01% 2992

Other funds holding CLSD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mariner's CLSD Position: Q3 2025 in Review

Mariner sold out of Clearside Biomedical (CLSD) in Q3 2025, closing a stake of 1,263 shares — an estimated $15.2K sold.

Mariner first reported a position in CLSD in Q4 2023 and held it in 7 quarters. The position peaked at $29K in Q1 2024. 26 funds tracked by Wall St. Rank hold CLSD as of Q3 2025.

  • Mariner reported no remaining Clearside Biomedical position as of Q3 2025 after selling out during the quarter.
  • Mariner sold 1,263 Clearside Biomedical shares in Q3 2025, an estimated $15.2K.
  • Mariner first reported a position in Clearside Biomedical in Q4 2023 and held it in 7 quarters.
  • Mariner's Clearside Biomedical position peaked at $29K in Q1 2024.
  • 26 funds tracked by Wall St. Rank held Clearside Biomedical as of Q3 2025.

Based on Mariner's 13F filing for Q3 2025, filed 14 Nov 2025.